In a month that can often see impressive gains in stock prices, Tuesday was not a January trading day to remember. The market’s various indexes generally traded sideways or slightly down. Few stocks were outstanding or even notable in their movements across the day.
That is, unless they were one of these two beauties. Read on for how and why these winners rose notably higher on the day.
Tilray (NASDAQ:TLRY) shareholders had a better trading day than most of us. The stock was quite the outperformer, even among other Tuesday highfliers.
Investors were very happy that the company managed to snag not one, but two new top-level executives with experience in the trenches of big, publicly traded companies.
New exec No. 1 is Michael Kruteck, the incoming CFO. Prior to serving in the same role for privately held retailer Pharmaca, he did a tour of duty at Molson Coors in a selection of executive roles. When he takes up his new post, he’ll displace current CFO Mark Castaneda, who will take on a business development role at Tilray.
The second new member of the marijuana company‘s C-suite is Jon Levin, who is to occupy the COO throne. Levin comes to Tilray from publicly traded cosmetics major Revlon, where he served as general manager for U.S. mass markets.
It’s certainly admirable and encouraging that Tilray, a…